Surprise! Pfizer And Lilly File Tanezumab For Pain With FDA Despite Safety Questions

Surprise confetti
The prospects for tanezumab are uncertain • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

More from Neurological

More from Therapeutic Category